RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 13,378 | $6,274 | 0.00% |
| EAGLE ASSET MANAGEMENT INC | 46,651 | $21,879 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 37,047 | $17,375 | 0.00% |
| MORGAN STANLEY | 200 | $94 | 0.00% |
| BlackRock Inc. | 271,484 | $127,326 | 0.00% |
| Bank of New York Mellon Corp | 56,298 | $26,404 | 0.00% |
| Citadel Advisors | 3,200 | $1,501 | 0.00% |
| Citadel Advisors | 66,525 | $31,200 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 24,807 | $11,634 | 0.00% |
External links
This page lists RECRO PHARMA INC's shareholders in Q3 2023. To view RECRO PHARMA INC's shareholder history, click here.